Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Journal of Acquired Immune Deficiency Syndromes (1999)|January 1, 2013
Tenofovir, emtricitabine intracellular and plasma, and efavirenz plasma concentration decay following drug intake cessation: implications for HIV treatment and preventionAkil Jackson, Graeme Moyle, Victoria Watson, et al.
The British Journal of Nutrition|February 12, 2019
Growth in early life and physical and intellectual development at school age: a cohort studyChao Li, Lingxia Zeng, Duolao Wang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 22, 2009
Pharmacokinetics and safety of etravirine administered once or twice daily after 2 weeks treatment with efavirenz in healthy volunteersMarta Boffito, Akil Jackson, Mohammed Lamorde, et al.
The Journal of Antimicrobial Chemotherapy|March 12, 2011
Pharmacokinetics and safety of the co-administration of the antiretroviral raltegravir and the lipid-lowering drug ezetimibe in healthy volunteersAkil Jackson, Antonio D'Avolio, Victoria Watson, et al.
Antimicrobial Agents and Chemotherapy|October 13, 2010
Plasma and intracellular (peripheral blood mononuclear cells) pharmacokinetics of once-daily raltegravir (800 milligrams) in HIV-infected patientsJosé Moltó, Marta Valle, David Back, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 20, 2011
Plasma and intracellular pharmacokinetics of darunavir/ritonavir once daily and raltegravir once and twice daily in HIV-infected individualsAkil Jackson, Victoria Watson, David Back, et al.
Journal of the International AIDS Society|March 26, 2019
Regulation of HIV self-testing in Malawi, Zambia and Zimbabwe: a qualitative study with key stakeholdersRussell J Dacombe, Victoria Watson, Lot Nyirenda, et al.
International Journal of Environmental Research and Public Health|January 18, 2020
Effect of Parental Migration on the Intellectual and Physical Development of Early School-Aged Children in Rural ChinaMinmin Li, Ni Zhu, Lingxia Zeng, et al.
Pageof 5